test44
https://www.cytel.com/blog/meet-our-global-heor-and-rwe-experts-virtual-ispor-2021
May 5, 2021
Cytel’s team of HEOR and RWE experts are all set to make a splash at the Virtual ISPOR on May 17 - 20. Our global..
Read article
test44
https://www.cytel.com/blog/advances-in-heor-an-interview-with-anna-forsythe
April 29, 2021
After twenty years in pharma, Anna Forsythe was frustrated by traditional vendors who used outdated methods to prepare..
Read article
test44
https://www.cytel.com/blog/cytel-and-ingress-health-at-virtual-ispor-europe-2020
November 24, 2020
Virtual ISPOR 2020, held November 16 to 19, presented new opportunities for scientific interaction amongst HEOR..
Read article
test44
https://www.cytel.com/blog/role-of-rwa-in-transforming-oncological-research
November 5, 2020
In oncology, many manufacturers go into niche indications, where there are very specific tumors, and then they opt for..
Read article
test44
https://www.cytel.com/blog/an-interview-with-bart-heeg-part-2-new-trends-in-heor
October 22, 2020
In this two-part blog series, we interview Bart Heeg, Vice President HEOR and Founder at Ingress Health (A Cytel..
Read article
test44
https://www.cytel.com/blog/interview-with-thomas-wilke-health-economics-and-real-world-evidence-studies
October 20, 2020
In this interview with Thomas Wilke, Principal Scientist at Ingress-Health (a Cytel company), we talk to him about his..
Read article
test44
https://www.cytel.com/blog/the-increasing-importance-of-health-economics-interview-with-bart-heeg-part-1
October 14, 2020
A credible evidence base is needed to support and document the economic value of new technologies and therapeutic..
Read article
test44
https://www.cytel.com/blog/introducing-observational-studies-three-trends-for-statisticians
October 13, 2020
The combination of greater access to electronic health records, bigger electronic claims datasets, and the need for..
Read article
